Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass., April 23, 2024 Omega Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today.